Market openNon-fractional

Wave Life Sciences/WVE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Wave Life Sciences

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Ticker

WVE

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Singapore, Singapore

Employees

267

WVE Metrics

BasicAdvanced
$651M
Market cap
-
P/E ratio
-$0.55
EPS
-1.04
Beta
-
Dividend rate
$651M
-1.04
1.186
1.091
70.944
91.796
-17.95%
-1,920.16%
5.319
25.73
25.73
-4.308
661.49%
-67.81%
92.15%
-45.52%

What the Analysts think about WVE

Analyst Ratings

Majority rating from 7 analysts.
Buy

WVE Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-252.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$13M
-56.90%
Net income
-$32M
94.44%
Profit margin
-252.00%
351.13%

WVE Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 12.15%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.20
$0.07
-$0.15
-$0.24
-
Expected
-$0.33
-$0.18
-$0.23
-$0.21
-$0.21
Surprise
-39.66%
-139.25%
-33.82%
12.15%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Wave Life Sciences stock?

Wave Life Sciences (WVE) has a market cap of $651M as of July 05, 2024.

What is the P/E ratio for Wave Life Sciences stock?

The price to earnings (P/E) ratio for Wave Life Sciences (WVE) stock is 0 as of July 05, 2024.

Does Wave Life Sciences stock pay dividends?

No, Wave Life Sciences (WVE) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Wave Life Sciences dividend payment date?

Wave Life Sciences (WVE) stock does not pay dividends to its shareholders.

What is the beta indicator for Wave Life Sciences?

Wave Life Sciences (WVE) has a beta rating of -1.04. This means that it has an inverse relation to market volatility.

Buy or sell Wave Life Sciences stock

Buy or sell Wave Life Sciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing